ConductScience.org, home

Paper1762089

The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.

Auchampach JA and 3 others. J Pharmacol Exp Ther, 1991. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. Papers, record 1762089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1762089

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
4.81
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Auchampach JAJ A
2Maruyama MM
3Cavero II
4Gross GJG J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HemodynamicsMajor topic
Myocardial InfarctionMajor topic
PicolinesMajor topic
Potassium ChannelsMajor topic
PyransMajor topic
Animals
Blood Glucose
Coronary Circulation
Coronary Vessels
Dogs
Female
Glyburide
Male
Myocardial Reperfusion Injury

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL 08311NHLBI NIH HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
26660852KATP Channels in the Cardiovascular System.Physiol Rev2016https://conductscience.org/library/papers/26660852PubMed
23730259Redox signaling pathways involved in neuronal ischemic preconditioning.Curr Neuropharmacol2012https://conductscience.org/library/papers/23730259PubMed
151482463',4'-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep.Br J Pharmacol2004https://conductscience.org/library/papers/15148246PubMed
12190121Ischemic shortening of action potential duration as a result of KATP channel opening attenuates myocardial stunning by reducing calcium influx.Mol Cell Biochem2002https://conductscience.org/library/papers/12190121PubMed
12167286Peroxidatic activity in heart effluent: a biochemical parameter for the assessment of experimental ischemia-reperfusion injury.J Cell Mol Med2000https://conductscience.org/library/papers/12167286PubMed
8922256Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.Basic Res Cardiol1996https://conductscience.org/library/papers/8922256PubMed
8897447The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle.Naunyn Schmiedebergs Arch Pharmacol1996https://conductscience.org/library/papers/8897447PubMed
8832065Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.Br J Pharmacol1996https://conductscience.org/library/papers/8832065PubMed
8795471K+ channel opening: a new drug principle in cardiovascular medicine.Heart1996https://conductscience.org/library/papers/8795471PubMed
8739909Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?Diabetologia1996https://conductscience.org/library/papers/8739909PubMed
8585863Effects of anesthesia and K+ ATP channel blockade on interstitial adenosine accumulation in ischemic rabbit myocardium.Basic Res Cardiol1995https://conductscience.org/library/papers/8585863PubMed
8581281Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.Br J Pharmacol1995https://conductscience.org/library/papers/8581281PubMed
8564215Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide.Br J Pharmacol1995https://conductscience.org/library/papers/8564215PubMed
8251422Role of ATP-sensitive K+ channel current in ischemic arrhythmias.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8251422PubMed
8032610Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1-agonist in the dog.Br J Pharmacol1994https://conductscience.org/library/papers/8032610PubMed
7989584Activation of potassium channels contributes to hypoxic injury in proximal tubules.J Clin Invest1994https://conductscience.org/library/papers/7989584PubMed
7952861Antiarrhythmic effects of BN-063, a newly synthesized adenosine A1 agonist, on myocardial ischaemia in rats.Br J Pharmacol1994https://conductscience.org/library/papers/7952861PubMed
7647966Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.Br J Pharmacol1995https://conductscience.org/library/papers/7647966PubMed
7647029Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.Cardiovasc Drugs Ther1995https://conductscience.org/library/papers/7647029PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1762089

GET https://conductscience.org/api/papers/v1/1762089/authors